WESTBROOK, ME - JANUARY 4: IDEXX Laboratories has been added to the Standard & Poor's 500 Index. (Photo by Ben McCanna/Portland Portland Press Herald via Getty Images) IDEXX Laboratories’ (IDXX) ...

The Organised Private Sector and the Nigeria Labour Congress have rejected calls for the introduction of higher-value currency notes, warning that the proposed move would not solve Nigeria’s economic ...

Gift 5 articles to anyone you choose each month when you subscribe. Sleep apnea device maker ResMed will expand its American manufacturing operations and open a new facility in Indianapolis in 2027 ...

ResMed Inc. (NYSE:RMD) reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of ...

ResMed posted a 9% revenue increase and an 11% rise in net income for the September quarter, driven by increased demand for sleep treatment products. The company demonstrated strong growth in various ...

A new economic review by Quartus Economics has urged the Central Bank of Nigeria to introduce higher-value currency notes such as N10,000 and N20,000 bills to restore the naira’s portability and ...

A fresh economic review by Quartus Economics has outlined why the Central Bank of Nigeria, CBN, should introduce higher-value currency notes such as N10,000 and N20,000. According to the report, ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

Michal studies Automotive Journalism at Coventry University in the UK, and has been writing for CarBuzz since March 2025. He was nominated for student culture piece of the year recently and has been ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

The ResMed Inc (ASX: RMD) share price is rising on Friday morning. At the time of writing, the sleep disorder treatment company's shares are up 2.5% to a record high of $43.47. This follows the ...

July 31 (Reuters) - Resmed (RMD.N), opens new tab beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company ...